FerGene
A spinout of Ferring Pharmaceuticals for late-phase gene therapy nadofaragene firadenovec.
Launch date
Employees
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$570m | Growth Equity VC | ||
Total Funding | €518m |
Related Content
Recent News about FerGene
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.